Causes and Predictors of 30-Day Readmission in Patients With Stroke Undergoing Mechanical Thrombectomy: A Large Single-Center Experience.
Journal
Neurosurgery
ISSN: 1524-4040
Titre abrégé: Neurosurgery
Pays: United States
ID NLM: 7802914
Informations de publication
Date de publication:
15 Jan 2024
15 Jan 2024
Historique:
received:
12
10
2023
accepted:
29
11
2023
medline:
15
1
2024
pubmed:
15
1
2024
entrez:
15
1
2024
Statut:
aheadofprint
Résumé
The 30-day readmission rate has emerged as a metric of quality care and is associated with increased health care expenditure. We aim to identify the rate and causes of 30-day readmission after mechanical thrombectomy and provide the risk factors of readmission to highlight high-risk patients who may require closer care. This is a retrospective study from a prospectively maintained database of 703 patients presenting for mechanical thrombectomy between 2017 and 2023. All patients who presented with a stroke and underwent a mechanical thrombectomy were included in this study. Patients who were deceased on discharge were excluded from this study. Our study comprised 703 patients, mostly female (n = 402, 57.2%) with a mean age of 70.2 years ±15.4. The most common causes of readmission were cerebrovascular events (stroke [n = 21, 36.2%], intracranial hemorrhage [n = 9, 15.5%], and transient ischemic attack [n = 1, 1.7%]).Other causes of readmission included cardiovascular events (cardiac arrest [n = 4, 6.9%] and bradycardia [n = 1, 1.7%]), infection (wound infection postcraniectomy [n = 3, 5.2%], and pneumonia [n = 1, 1.7%]). On multivariate analysis, independent predictors of 30-day readmission were history of smoking (odds ratio [OR]: 2.2, 95% CI: 1.1-4.2) P = .01), distal embolization (OR: 3.2, 95% CI: 1.1-8.7, P = .03), decompressive hemicraniectomy (OR: 9.3, 95% CI: 3.2-27.6, P < .01), and intracranial stent placement (OR: 4.6, 95% CI: 2.4-8.7) P < .01). In our study, the rate of 30-day readmission was 8.3%, and the most common cause of readmission was recurrent strokes. We identified a history of smoking, distal embolization, decompressive hemicraniectomy, and intracranial stenting as independent predictors of 30-day readmission in patients with stroke undergoing mechanical thrombectomy.
Sections du résumé
BACKGROUND AND OBJECTIVES
OBJECTIVE
The 30-day readmission rate has emerged as a metric of quality care and is associated with increased health care expenditure. We aim to identify the rate and causes of 30-day readmission after mechanical thrombectomy and provide the risk factors of readmission to highlight high-risk patients who may require closer care.
METHODS
METHODS
This is a retrospective study from a prospectively maintained database of 703 patients presenting for mechanical thrombectomy between 2017 and 2023. All patients who presented with a stroke and underwent a mechanical thrombectomy were included in this study. Patients who were deceased on discharge were excluded from this study.
RESULTS
RESULTS
Our study comprised 703 patients, mostly female (n = 402, 57.2%) with a mean age of 70.2 years ±15.4. The most common causes of readmission were cerebrovascular events (stroke [n = 21, 36.2%], intracranial hemorrhage [n = 9, 15.5%], and transient ischemic attack [n = 1, 1.7%]).Other causes of readmission included cardiovascular events (cardiac arrest [n = 4, 6.9%] and bradycardia [n = 1, 1.7%]), infection (wound infection postcraniectomy [n = 3, 5.2%], and pneumonia [n = 1, 1.7%]). On multivariate analysis, independent predictors of 30-day readmission were history of smoking (odds ratio [OR]: 2.2, 95% CI: 1.1-4.2) P = .01), distal embolization (OR: 3.2, 95% CI: 1.1-8.7, P = .03), decompressive hemicraniectomy (OR: 9.3, 95% CI: 3.2-27.6, P < .01), and intracranial stent placement (OR: 4.6, 95% CI: 2.4-8.7) P < .01).
CONCLUSION
CONCLUSIONS
In our study, the rate of 30-day readmission was 8.3%, and the most common cause of readmission was recurrent strokes. We identified a history of smoking, distal embolization, decompressive hemicraniectomy, and intracranial stenting as independent predictors of 30-day readmission in patients with stroke undergoing mechanical thrombectomy.
Identifiants
pubmed: 38224235
doi: 10.1227/neu.0000000000002826
pii: 00006123-990000000-01021
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © Congress of Neurological Surgeons 2024. All rights reserved.
Références
Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360(14):1418-1428.
Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56-e528.
Huang JF. Prevention and management of poststroke complications. Continuum (Minneap Minn). 2017;23(1, Cerebrovascular Disease):93-110.
Shah SV, Corado C, Bergman D, et al. Impact of poststroke medical complications on 30-day readmission rate. J Stroke Cerebrovasc Dis. 2015;24(9):1969-1977.
Strowd RE, Wise SM, Umesi UN, et al. Predictors of 30-day hospital readmission following ischemic and hemorrhagic stroke. Am J Med Qual. 2015;30(5):441-446.
Zhong W, Geng N, Wang P, Li Z, Cao L. Prevalence, causes and risk factors of hospital readmissions after acute stroke and transient ischemic attack: a systematic review and meta-analysis. Neurol Sci. 2016;37(8):1195-1202.
Quinn TJ, Dawson J, Walters MR, Lees KR. Reliability of the modified Rankin Scale: a systematic review. Stroke. 2009;40(10):3393-3395.
Uchida K, Shindo S, Yoshimura S, et al. Association between Alberta Stroke Program early computed tomography score and efficacy and safety outcomes with endovascular therapy in patients with stroke from large-vessel occlusion: a secondary analysis of the recovery by endovascular salvage for cerebral ultra-acute embolism-Japan large ischemic core trial (RESCUE-Japan LIMIT). JAMA Neurol. 2022;79(12):1260-1266.
Kazi SA, Siddiqui M, Majid S. Stroke outcome prediction using admission Nihss in anterior and posterior circulation stroke. J Ayub Med Coll Abbottabad. 2021;33(2):274-278.
Mouchtouris N, Al Saiegh F, Valcarcel B, et al. Predictors of 30-day hospital readmission after mechanical thrombectomy for acute ischemic stroke. J Neurosurg. 2020;134(5):1500-1504.
Bjerkreim AT, Thomassen L, Brøgger J, Waje-Andreassen U, Næss H. Causes and predictors for hospital readmission after ischemic stroke. J Stroke Cerebrovasc Dis. 2015;24(9):2095-2101.
Lichtman JH, Leifheit-Limson EC, Jones SB, Wang Y, Goldstein LB. Preventable readmissions within 30 days of ischemic stroke among Medicare beneficiaries. Stroke. 2013;44(12):3429-3435.
Lin HJ, Chang WL, Tseng MC. Readmission after stroke in a hospital-based registry: risk, etiologies, and risk factors. Neurology. 2011;76(5):438-443.
Ramchand P, Thibault DP, Crispo JA, et al. Readmissions after mechanical thrombectomy for acute ischemic stroke in the United States: a nationwide analysis. J Stroke Cerebrovasc Dis. 2018;27(10):2632-2640.
Vahidy FS, Donnelly JP, McCullough LD, et al. Nationwide estimates of 30-day readmission in patients with ischemic stroke. Stroke. 2017;48(5):1386-1388.
Rao A, Barrow E, Vuik S, Darzi A, Aylin P. Systematic review of hospital readmissions in stroke patients. Stroke Res Treat. 2016;2016:9325368.
Burke JF, Skolarus LE, Adelman EE, Reeves MJ, Brown DL. Influence of hospital-level practices on readmission after ischemic stroke. Neurology. 2014;82(24):2196-2204.
Kobayashi H, Hoshino M, Okayama K, Sekizawa K, Sasaki H. Swallowing and cough reflexes after onset of stroke. Chest. 1994;105(5):1623.
Chang Y, Kim BM, Bang OY, et al. Rescue stenting for failed mechanical thrombectomy in acute ischemic stroke: a multicenter experience. Stroke. 2018;49(4):958-964.
Labeyrie MA, Civelli V, Reiner P, et al. Prevalence and treatment of spontaneous intracranial artery dissections in patients with acute stroke due to intracranial large vessel occlusion. J Neurointerv Surg. 2018;10(8):761-764.
Maingard J, Phan K, Lamanna A, et al. Rescue intracranial stenting after failed mechanical thrombectomy for acute ischemic stroke: a systematic review and meta-analysis. World Neurosurg. 2019;132:e235-e245.